Drug Shortage Report for ATIVAN

Last updated on 2017-12-13 History
Report ID 31935
Drug Identification Number 02041464
Brand name ATIVAN
Common or Proper name ATIVAN
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) LORAZEPAM
Strength(s) 1MG
Dosage form(s) TABLET
Route of administration SUBLINGUAL
Packaging size 1X100 TAB/BTL
ATC code N05BA
ATC description ANXIOLYTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-12-14
Actual start date
Estimated end date 2017-12-18
Actual end date 2017-12-12
Shortage status Avoided shortage
Updated date 2017-12-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2017-12-13 French Compare
v3 2017-12-13 English Compare
v2 2017-12-06 French Compare
v1 2017-12-06 English Compare

Showing 1 to 4 of 4